← Open Payments lookup

HEATHER WHITTAKER: Open Payments

NPI 1235821141 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,311 in 65 payments from 18 companies in 2025. Trend: 2023 $761 · 2024 $1,610 · 2025 $1,311

Food & beverage: $1,311
CompanyPaymentsAmount
Novo Nordisk Inc15$352
Lilly USA, LLC9$175
ABBVIE INC.8$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$97
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$89
Boehringer Ingelheim Pharmaceuticals, Inc.3$71
PFIZER INC.4$69
Lundbeck LLC2$46
AstraZeneca Pharmaceuticals LP2$44
Merck Sharp & Dohme LLC2$43

Products named: MOUNJARO, Rybelsus, JARDIANCE, Wegovy, Ozempic, CAPLYTA, XIFAXAN, VRAYLAR.

Industry payments across MD — which companies pay providers there.